Unknown

Dataset Information

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial.


ABSTRACT:

Importance

To achieve hepatitis C elimination, treatment programs need to engage, treat, and cure people who inject drugs.

Objective

To compare a low-threshold, nonstigmatizing hepatitis C treatment program that was colocated at a syringe service program (accessible care) with facilitated referral to local clinicians through a patient navigation program (usual care).

Design, setting, and participants

This single-site randomized clinical trial was conducted at the Lower East Side Harm Reduction Center, a syringe service program in New York, New York, and included 167 participants who were hepatitis C virus RNA-positive and had injected drugs during the prior 90 days. Participants enrolled between July 2017 and March 2020. Data were analyzed after all patients completed

SUBMITTER: Eckhardt B 

PROVIDER: S-EPMC8922207 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature